{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:36:25Z","timestamp":1648978585554},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":730,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1002\/2327-6924.12053","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T03:53:44Z","timestamp":1377662024000},"page":"488-494","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic options for lowering LDL-C in type 2 diabetes: A nurse practitioner's perspective"],"prefix":"10.1097","volume":"25","author":[{"given":"Kelley Newlin","family":"Lew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica A.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail D'Eramo","family":"Melkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R5-7-20210924","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/0145721706298308","article-title":"AADE position statement: Individualization of diabetes selfmanagement education.","volume":"33","year":"2007","journal-title":"The Diabetes Educator"},{"issue":"Suppl 1","key":"R6-7-20210924","first-page":"S11","article-title":"Standards of medical care in diabetes2013.","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"R8-7-20210924","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1475-2840-9-20","article-title":"Ezetimibe simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: A multicenter, randomized trial (the LEAD study).","volume":"9","author":"Bardini","year":"2010","journal-title":"Cardiovascular Diabetology"},{"key":"R9-7-20210924","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/archinte.168.18.1975","article-title":"Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: Glucose and lipid effects.","volume":"168","author":"Bays","year":"2008","journal-title":"Archives of Internal Medicine"},{"key":"R10-7-20210924","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2337\/dc08-9018","article-title":"Lipoprotein management in patients with cardiometabolic risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.","volume":"31","author":"Brunzell","year":"2008","journal-title":"Diabetes Care"},{"key":"R11-7-20210924","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterollowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: A metaanalysis.","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"R12-7-20210924","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.amjcard.2008.09.075","article-title":"Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.","volume":"102","author":"Conard","year":"2008","journal-title":"American Journal of Cardiology"},{"key":"R13-7-20210924","first-page":"1","article-title":"Prevalence of selected risk behaviors and chronic diseases and conditionssteps communities, United States, 2006-2007.","volume":"59","author":"Cory","year":"2010","journal-title":"Morbidity and Mortality Weekly Report Surveillance Summaries"},{"key":"R14-7-20210924","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3132\/dvdr.2006.020","article-title":"Ezetimibe added to ongoing statin therapy improves LDLC goal attainment and lipid profile in patients with diabetes or metabolic syndrome.","volume":"3","author":"Denke","year":"2006","journal-title":"Diabetes Vascular Disease Research"},{"key":"R15-7-20210924","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10year followup of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.","volume":"374","year":"2009","journal-title":"Lancet"},{"key":"R18-7-20210924","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1742-1241.2009.02022.x","article-title":"Lipidaltering efficacy of ezetimibesimvastatin 1020 mg compared with rosuvastatin 10 mg in highrisk hypercholesterolaemic patients inadequately controlled with prior statin monotherapyThe INCROSS Study.","volume":"63","author":"Farnier","year":"2009","journal-title":"International Journal of Clinical Practice"},{"key":"R19-7-20210924","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc08-0283","article-title":"Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylureabased therapy.","volume":"31","author":"Fonseca","year":"2008","journal-title":"Diabetes Care"},{"key":"R20-7-20210924","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3810\/psm.2011.05.1898","article-title":"Exercise and diet, independent of weight loss, improve cardiometabolic risk profile in overweight and obese individuals.","volume":"39","author":"Gaesser","year":"2011","journal-title":"The Physician and Sportsmedicine"},{"key":"R21-7-20210924","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1463-1326.2004.00420.x","article-title":"Efficacy and safety of ezetimibe coadministered with simvastatin in thiazolidinedionetreated type 2 diabetic patients.","volume":"7","author":"Gaudiani","year":"2005","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"R22-7-20210924","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archinte.168.14.1531","article-title":"Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulinbased therapy.","volume":"168","author":"Goldberg","year":"2008","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl 2","key":"R24-7-20210924","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.17.S2.1","article-title":"American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan.","volume":"17","author":"Handelsman","year":"2011","journal-title":"Endocrine Practice"},{"key":"R25-7-20210924","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/diacare.29.02.06.dc05-1299","article-title":"Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors.","volume":"29","author":"Howard","year":"2006","journal-title":"Diabetes Care"},{"key":"R26-7-20210924","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.clinthera.2010.04.014","article-title":"Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12week, multicenter, randomized, doubleblind, controlled trial.","volume":"32","author":"Huijgen","year":"2010","journal-title":"Clinical Therapeutics"},{"issue":"Suppl 1","key":"R27-7-20210924","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.18.S1.1","article-title":"American Association of Clinical Endocrinologists Guidelines for management of dyslipidemia and prevention of atherosclerosis.","volume":"18","author":"Jellinger","year":"2012","journal-title":"Endocrine Practice"},{"key":"R28-7-20210924","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/met.2009.0007","article-title":"Concomitant reduction in lowdensity lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: A pooled analysis.","volume":"7","author":"Jialal","year":"2009","journal-title":"Metabolic Syndrome and Related Disorders"},{"key":"R30-7-20210924","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1503\/cmaj.070675","article-title":"The efficacy and safety of intensive statin therapy: A metaanalysis of randomized trials.","volume":"178","author":"Josan","year":"2008","journal-title":"Canadian Medical Association Journal"},{"key":"R31-7-20210924","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/diacare.28.5.1029","article-title":"The challenge of achieving national cholesterol goals in patients with diabetes.","volume":"28","author":"Kennedy","year":"2005","journal-title":"Diabetes Care"},{"key":"R33-7-20210924","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(12)61426-3","article-title":"Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: A cohort study.","volume":"381","author":"Kokkinos","year":"2013","journal-title":"Lancet"},{"key":"R37-7-20210924","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2105\/AJPH.80.8.954","article-title":"The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT).","volume":"80","author":"Ockene","year":"1990","journal-title":"American Journal of Public Health"},{"key":"R38-7-20210924","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensivedose compared with moderatedose statin therapy: A metaanalysis.","volume":"305","author":"Preiss","year":"2011","journal-title":"Journal of the American Medical Association"},{"key":"R39-7-20210924","doi-asserted-by":"crossref","first-page":"e001472","DOI":"10.1136\/bmjopen-2012-001472","article-title":"Do statins interfere with lifestyle intervention in the prevention of diabetes in primary healthcare? Oneyear followup of the FIND2D project.","volume":"2","author":"Rautio","year":"2012","journal-title":"BMJ Open"},{"key":"R40-7-20210924","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1742-1241.2008.01697.x","article-title":"Lipidaltering efficacy of ezetimibesimvastatin 1040 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: The INFORCE study.","volume":"62","author":"Reckless","year":"2008","journal-title":"International Journal of Clinical Practice"},{"issue":"Suppl 9B","key":"R41-7-20210924","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/S0002-9343(01)00987-1","article-title":"Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease.","volume":"113","author":"Sacks","year":"2002","journal-title":"American Journal of Medicine"},{"key":"R42-7-20210924","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262 525 participants in 29 Western prospective studies.","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"R43-7-20210924","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: A collaborative metaanalysis of randomised statin trials.","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"R44-7-20210924","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-151-9-200911030-00144","article-title":"Systematic review: Comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.","volume":"151","author":"Sharma","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"R45-7-20210924","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.clinthera.2007.02.008","article-title":"Metaanalysis of druginduced adverse events associated with intensivedose statin therapy.","volume":"29","author":"Silva","year":"2007","journal-title":"Clinical Therapeutics"},{"key":"R46-7-20210924","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jada.2008.08.007","article-title":"Position of the American Dietetic Association: Health implications of dietary fiber.","volume":"108","author":"Slavin","year":"2008","journal-title":"Journal of the American Dietetic Association"},{"key":"R47-7-20210924","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHAACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation.","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"R48-7-20210924","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.","volume":"36","author":"Stark Casagrande","year":"2013","journal-title":"Diabetes Care"},{"key":"R49-7-20210924","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.amjmed.2004.01.009","article-title":"Exercisebased rehabilitation for patients with coronary heart disease: Systematic review and metaanalysis of randomized controlled trials.","volume":"116","author":"Taylor","year":"2004","journal-title":"American Journal of Medicine"},{"key":"R3-7-20210924","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus.","volume":"362","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"R4-7-20210924","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.","volume":"365","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"R34-7-20210924","first-page":"1566","article-title":"Longterm effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: Fouryear results of the Look AHEAD trial.","volume":"170","year":"2010","journal-title":"Archives of Internal Medicine"}],"container-title":["Journal of the American Association of Nurse Practitioners"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2F2327-6924.12053","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01741002-201309000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T18:46:30Z","timestamp":1632509190000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01741002-201309000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/2327-6924.12053","relation":{},"ISSN":["2327-6924"],"issn-type":[{"value":"2327-6924","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}